USTR Tai: US to back waiver of vaccine IP protections at WTO
The US will support a proposal to waive intellectual property protections for COVID-19 vaccines, in order to increase global supply and access to the life-saving shots, the country’s Trade Representative Katherine Tai said in an interview on Wednesday.
Key quotes
“We are for the waiver at the WTO, we are for what the proponents of the waiver are trying to accomplish, which is better access, more manufacturing capability, more shots in arms.”
“In terms of how soon the WTO can deliver -- that literally depends on the WTO members, collectively, being able to deliver, and so I am the first one to admit that what we are leaning into is a process that is not going to be easy.”
“Sees energy from WTO Director-General Ngozi Okonjo-Iweala “to take this opportunity and see what is the WTO capable of.”
Market reaction
In reaction to the above comments, Shares of Moderna Inc., Pfizer Inc., BioNTech SE and Novavax Inc, as drugmakers believe that the plan is ineffective.
Author
Dhwani Mehta
FXStreet
Residing in Mumbai (India), Dhwani is a Senior Analyst and Manager of the Asian session at FXStreet. She has over 10 years of experience in analyzing and covering the global financial markets, with specialization in Forex and commodities markets.
